Abstract:Background Systemic sclerosis (SSc) is a chronic inflammatory disease with complex pathogenesis. The role of regulatory T cells (Tregs) in the development of SSc has started being studied during the last decade with new aspects being disclosed continuously. Although there is a general agreement in the medical literature regarding the decreased functional capacity of circulating Tregs in SSc, the alteration of absolute number of Treg and Th17 cells as well as their associations with clinical characteristics of SSc are still unclear. Objectives The aim of the present study was to explore the relationship between absolute reduction of peripheral CD4 +regulatory T and Th17 cell subset and clinical characteristics in SSc patients. Methods The peripheral CD4 +T subsets from 54 patients with SSc and 30 healthy control subjects were analysed. The patients were divided into the untreated group (n=29) and treated group (n=25). The patients were also divided into group 1 (n=9) for the prominent pulmonary lesions, group 2 (n=5) for prominent esophageal involvement, group 3 (n=8) for both lung lesions and esophageal involvement, and group 4 (n=10) who had fingers swelling, sclerosis, ulceration prominent. Directly using the results from flow cytometry combined with internal standard beads, absolute number of peripheral Th17 and Treg cells from the subjects in each group were calculated. Results Although there were some changes among CD4 +T cell subsets in peripheral blood from these SSc patients, the major alteration was the reductions of Treg cell absolute number. Compared with the normal controls, the number of CD4+CD25+FOXP3+Treg cells were significantly decreased in untreated group (p=0.029) , in group 1 (p=0.014) and in group 2 (p=0.073) as compared with heathy controls. Interestingly, Tregs in group 2 were significantly lower than those in group 1 (p=0.006), in group 3(p=0.098) and in group 4(p=0.034). In addition, the number of Th17 cells were significantly higher in group 3 (p=0.003 and 4 (p Conclusions The absolute number of peripheral CD4 +CD25+FOXP3+Treg cells decreased in untreated patients, indicating that this reduction arising from the disease itself. Our findings suggest that the severity of clinical manifestations in patients with SSc is related to the absolute decrease of peripheral Treg cells. Although there was no statistically significant different, absolute number of the Treg cells trended to decrease in patients who had more severe clinical manifestations. With the involvement of vital organs, the absolute number of Treg cells decreased more significantly. Moreover, in patients with relatively mild clinical manifestations, the increase in the absolute number of Th17 cells is even more obvious, suggesting that Th17 also plays an important role in early and intermediate stages. Disclosure of Interest None declared

Aberrant Histone Modification in Peripheral Blood B Cells from Patients with Systemic Sclerosis.

Alterations in peripheral T‐ and B‐cell subsets in patients with systemic sclerosis

FRI0450 Associations of alterations of peripheral regulatory t and th17 absolute cell numbers with clinical features in patients with systemic sclerosis

Distinct T cell chromatin landscapes in scleroderma subtypes

Hypomethylation and overexpression of ITGAL (CD11a) in CD4 + T cells in systemic sclerosis

Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis.

Changes in peripheral T-lymphocyte subsets and serum cytokines in patients with systemic sclerosis

DIFFERENTIAL EXPRESSION OF PERIPHERAL CD4+T CELLS IN PATIENTS WITH SYSTEMIC SCLEROSIS AND MIXED CONNECTIVE TISSUE DISEASE

New insights into CD4(+) T cell abnormalities in systemic sclerosis.

Lymphocyte subset abnormalities in early diffuse cutaneous systemic sclerosis

Cytokine‐producing B‐cell balance associates with skin fibrosis in patients with systemic sclerosis

Role of B-Cell in the Pathogenesis of Systemic Sclerosis

Role of Epigenetics in the Pathogenesis of Systemic Sclerosis

The Abnormal Expression of Histone Deacetylase 8 in Labial Gland B Cells and Plasma Cells of Sj?gren's Syndrome

Expression and clinical significance of HMGB1 and sRAGE in patients with systemic sclerosis

Involvement of Disabled-2 on Skin Fibrosis in Systemic Sclerosis.

[Application of Lymphocytes Test in Peripheral Blood of Patients with Systemic Sclerosis During the Treatment].

Aberrant H3K4me3 modification of immune response genes in CD4 + T cells of patients with systemic lupus erythematosus

Genome-Wide DNA Methylation Analysis in Systemic Sclerosis Reveals Hypomethylation of IFN-Associated Genes in CD4+ and CD8+ T Cells.

Dendritic cells drive profibrotic inflammation and aberrant T cell polarization in systemic sclerosis

Integrative Transcriptomic Analysis of Peripheral Blood Monocytes in Systemic Sclerosis and Shared Pathogenic Pathways in Autoimmune Diseases